Dr. Pedro Colton, M.D

NPI: 1104001270
Total Payments
$11,747
2024 Payments
$2,625
Companies
30
Transactions
214
Medicare Patients
636
Medicare Billing
$164,359

Payment Breakdown by Category

Food & Beverage$11,474 (97.7%)
Education$272.28 (2.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $11,474 201 97.7%
Education $272.28 13 2.3%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $2,049 54 $0 (2024)
Janssen Pharmaceuticals, Inc $1,720 23 $0 (2024)
Mallinckrodt Hospital Products Inc. $854.71 14 $0 (2024)
Mallinckrodt Enterprises LLC $706.68 8 $0 (2019)
E.R. Squibb & Sons, L.L.C. $634.63 6 $0 (2023)
Bayer Healthcare Pharmaceuticals Inc. $602.78 16 $0 (2024)
SANOFI-AVENTIS U.S. LLC $581.41 17 $0 (2022)
Merck Sharp & Dohme Corporation $470.36 5 $0 (2019)
Horizon Therapeutics plc $451.04 4 $0 (2023)
Amgen Inc. $436.18 11 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,625 49 Fennec Pharmaceuticals, Inc. ($428.80)
2023 $1,692 30 AstraZeneca Pharmaceuticals LP ($400.10)
2022 $1,377 31 AstraZeneca Pharmaceuticals LP ($258.44)
2021 $816.90 18 Mallinckrodt Hospital Products Inc. ($362.73)
2020 $1,004 24 AstraZeneca Pharmaceuticals LP ($447.63)
2019 $2,146 28 Janssen Pharmaceuticals, Inc ($375.17)
2018 $1,511 23 Janssen Pharmaceuticals, Inc ($510.08)
2017 $575.76 11 Janssen Pharmaceuticals, Inc ($297.50)

All Payment Transactions

214 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
12/09/2024 Vifor Pharma, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $19.44 General
Category: Hyperkalemia
12/03/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $27.29 General
Category: Cardiovascular and Metabolism
11/18/2024 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $24.34 General
Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA
11/17/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Education In-kind items and services $10.60 General
Category: IMMUNOLOGY
10/23/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $25.00 General
Category: DIABETES
10/02/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $17.90 General
Category: Inflammation
10/01/2024 Bayer Puerto Rico Inc. Kerendia (Drug) Food and Beverage In-kind items and services $33.27 General
Category: Cardio-renal
09/27/2024 Kyowa Kirin, Inc. Crysvita (Drug) Food and Beverage In-kind items and services $118.71 General
Category: fibroblast growth factor 23 (FGF23) blocking antibody.
09/26/2024 Medtronic, Inc. ELLIPSYS VASCULAR ACCESS SYSTEM (Device) Food and Beverage In-kind items and services $132.05 General
Category: Catheters
09/19/2024 Medtronic, Inc. ELLIPSYS VASCULAR ACCESS SYSTEM (Device) Food and Beverage In-kind items and services $27.27 General
Category: Catheters
09/16/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $80.00 General
Category: Cardiovascular & Metabolism
09/10/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $25.00 General
Category: DIABETES
09/10/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $8.18 General
Category: Inflammation
08/23/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $115.48 General
08/23/2024 GlaxoSmithKline, LLC. BENLYSTA (Biological) Food and Beverage In-kind items and services $45.10 General
Category: IMMUNOLOGY
08/20/2024 Bayer Puerto Rico Inc. Kerendia (Drug) Food and Beverage In-kind items and services $34.95 General
Category: Cardio-renal
08/20/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $7.67 General
Category: Inflammation
08/10/2024 Kyowa Kirin, Inc. Crysvita (Drug) Food and Beverage In-kind items and services $29.81 General
Category: fibroblast growth factor 23 (FGF23) blocking antibody.
07/23/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $20.00 General
Category: Cardiovascular and Metabolism
07/22/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $6.62 General
Category: Inflammation
07/17/2024 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $122.04 General
Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA
07/03/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $25.00 General
Category: Cardiovascular and Metabolism
06/29/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $77.35 General
Category: Cardio-renal
06/24/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Education In-kind items and services $10.60 General
Category: IMMUNOLOGY
06/20/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $107.95 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 126 270 $28,723 $20,462
2022 4 115 264 $36,075 $26,264
2021 8 209 547 $79,060 $60,811
2020 7 186 530 $74,204 $56,822
Total Patients
636
Total Services
1,611
Medicare Billing
$164,359
Procedure Codes
24

All Medicare Procedures & Services

24 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 58 128 $12,056 $8,240 68.4%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 14 72 $7,448 $5,754 77.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 18 20 $4,128 $2,593 62.8%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 22 23 $3,153 $2,355 74.7%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 14 27 $1,938 $1,520 78.4%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2022 12 56 $16,839 $13,085 77.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 63 134 $12,376 $7,909 63.9%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 22 50 $3,590 $2,813 78.4%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 18 24 $3,271 $2,457 75.1%
90961 Dialysis services (2-3 physician visits per month), patient 20 years of age and older Office 2021 20 104 $31,272 $24,038 76.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 74 158 $14,658 $10,671 72.8%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 34 148 $10,629 $8,449 79.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 13 50 $5,172 $4,138 80.0%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 33 38 $5,192 $4,032 77.7%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Office 2021 12 13 $4,722 $3,778 80.0%
90962 Dialysis services (1 physician visit per month), patient 20 years of age and older Office 2021 12 21 $4,326 $3,299 76.2%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 11 15 $3,090 $2,407 77.9%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Office 2020 17 64 $18,644 $13,967 74.9%
90961 Dialysis services (2-3 physician visits per month), patient 20 years of age and older Office 2020 16 66 $16,273 $12,749 78.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 39 197 $14,647 $11,445 78.1%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 48 64 $8,905 $6,908 77.6%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 21 63 $6,816 $5,322 78.1%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 22 24 $4,947 $3,659 74.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 23 52 $3,971 $2,772 69.8%

About Dr. Pedro Colton, M.D

Dr. Pedro Colton, M.D is a Nephrology healthcare provider based in San Juan, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2008. The National Provider Identifier (NPI) number assigned to this provider is 1104001270.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pedro Colton, M.D has received a total of $11,747 in payments from pharmaceutical and medical device companies, with $2,625 received in 2024. These payments were reported across 214 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($11,474).

As a Medicare-enrolled provider, Colton has provided services to 636 Medicare beneficiaries, totaling 1,611 services with total Medicare billing of $164,359. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Location San Juan, PR
  • Active Since 01/08/2008
  • Last Updated 12/06/2012
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1104001270

Products in Payments

  • ACTHAR (Biological) $1,561
  • LOKELMA (Drug) $1,341
  • XARELTO (Drug) $1,057
  • Kerendia (Drug) $922.20
  • ELIQUIS (Drug) $745.44
  • FARXIGA (Drug) $696.64
  • INVOKANA (Drug) $557.93
  • KRYSTEXXA (Biological) $451.04
  • Pedmark (Drug) $428.80
  • JARDIANCE (Drug) $249.86
  • BENLYSTA (Biological) $241.24
  • TAVNEOS (Drug) $195.21
  • ZERBAXA (Drug) $187.59
  • JANUVIA (Drug) $182.77
  • Uloric (Drug) $163.59
  • SOLIQUA 100/33 (Biological) $160.00
  • ELLIPSYS VASCULAR ACCESS SYSTEM (Device) $159.32
  • Crysvita (Drug) $148.52
  • PURIFIED CORTROPHIN GEL (Drug) $146.38
  • TARPEYO (Drug) $124.92

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in San Juan